Alabama Therapeutics CRS — Birmingham, Alabama

Alabama Therapeutics CRS is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Alabama Therapeutics CRS has participated in 43 clinical trials.

Therapeutic areas: HIV Infections, Sexually Transmitted Diseases, Peripheral Nervous System Disease.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alabama Therapeutics CRS?

Alabama Therapeutics CRS has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alabama Therapeutics CRS conducted?

Alabama Therapeutics CRS has 43 clinical trials on record. Their work covers HIV Infections, Sexually Transmitted Diseases, Peripheral Nervous System Disease.

Is Alabama Therapeutics CRS accredited by Crixeo Health?

Yes — Alabama Therapeutics CRS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Alabama Therapeutics CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.